CP-866087

DB12196InvestigationalSmall molecule

CP-866,087 has been used in trials studying the treatment of Obesity, Alcoholism, and Sexual Dysfunction, Physiological.

Mechanism: Pharmacologically active on Mu-type opioid receptor
Curator reviewed
Formula / weight: C₂₄H₃₀N₂O₃S · 426.58 g/mol (avg)
Code names: CP-866,087

Resolves to

Compound

Structure

InChIKeyZBVPUFSKFGYNLC-FIDNPTQWSA-NSMILESCC[C@]1([C@H]2CN(CC3(O)CC4=CC=CC=C4C3)C[C@@H]12)C1=CC=CC(NS(C)(=O)=O)=C1

Targets

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with CP-866087, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.